PER 3.80% 7.6¢ percheron therapeutics limited

Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing, page-19

  1. 518 Posts.
    lightbulb Created with Sketch. 91
    i'd be surprised if they don't read HC just to test the temperature of their retail holders at least (nothing more) and as we have hit IMO 'peak feral ness' on here post the quarterly, and a dump of shares, we might see a little more of CG and AF to smooth the water's

    It was nice to read CG's comment in today's announcement, gives me peace of mind
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.